Lynne Spinks

Lynne Spinks is a seasoned marketing professional with extensive experience in the pharmaceutical industry, currently serving as the I&I Marketing Director at Pfizer. They held various significant roles at Pfizer, including Commercial Director and Associate Commercial Director, where they led marketing strategies for both inline and pipeline assets. Prior to their tenure at Pfizer, Lynne gained valuable experience at Aventis Pharmaceutical, serving in multiple capacities, including Sole Brand Manager for a chemotherapy agent. Their leadership in the strategic re-direction of Eliquis contributed to it becoming the #1 oral anticoagulant in the market by June 2017.